Acquisition of extended-spectrum b-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors Extended-spectrum b-lactamases (ESBLs) are bacterial enzymes that confer resistance to advanced generation cephalosporins and can lead to therapeutic failures. There has been no analysis of factors associated with the risk of acquisition of ESBLs in neonates in an intensive care unit from northern India. The CTX-M ESBL enzymes impart resistance against advanced generation cephalosporins (e.g. cefotaxime) and CTX-M variants have become the most prevalent ESBLs worldwide. The CTX-M-15 enzyme in particular is increasingly being reported from Escherichia coli isolates from northern India together with TEM-1. Moreover, E. coli is the most common cause of neonatal sepsis. Accordingly, this study aimed to: (i) characterize the mode of transmission of bla CTX-M and bla TEM among ESBL-producing E. coli strains isolated from patients admitted to a neonatal intensive care unit (NICU), and (ii) identify factors associated with the acquisition of the said strains in male and female neonates. A total of 97 ESBL-producers was identified among 266 E. coli strains isolated from 238 neonates. The isolates were screened for bla CTX-M , bla TEM , armA, rmtA and rmtB, the last three genes being responsible for aminoglycoside resistance. PCR amplified bla CTX-M genes were cloned and sequenced. Five bla CTX-M-15 , two rmtB, two bla TEM-1 and thirteen class1 integrons were detected. All the bla CTX-M-15 positive isolates, except one, were clonally related. Both univariate and multivariate analyses of factors for the acquisition of the said strains were performed with respect to the sex of the neonates. 'Length of stay in the NICU' was found to be the single independent factor associated with ESBL acquisition. In conclusion, our data suggest that male neonates who are colonized or infected by ESBL-producing E. coli have a longer stay in the NICU compared to their female counterparts. This prolonged stay may be due to male neonates becoming colonized/infected earlier than their female counterparts. Plasmid-mediated-conjugal transfer was found to be the mechanism of transfer of the bla CTX-M-15 resistance marker in the described setting.
INTRODUCTION
The prevalence of multidrug-resistant bacteria in hospital environments has become a matter of due concern (Shakil et al., 2008) . Extended-spectrum b-lactamases (ESBLs) are bacterial enzymes that confer resistance to advanced generation cephalosporins and can lead to the therapeutic failure of these agents. ESBLs are often plasmid associated and there can be cross-species dissemination of these plasmids. Moreover, these plasmids often carry genes encoding co-resistance to other antibiotics such as aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol and sulfamethoxazole-trimethoprim, to name a few. Concomitant b-lactam and aminoglycoside resistance involving armA and rmtB genes is increasingly being reported (Ma et al., 2009) . Outbreaks by ESBL-producing organisms have been described frequently in neonatal intensive care unit (NICU) settings (Bagattini et al., 2006) . CTX-Ms are a class of ESBLs that are named after the antibiotic 'cefotaxime'. CTX-Ms also impart resistance against other advanced generation cephalosporins (e.g. ceftazidime).
IP: 54.70.40.11
On: Wed, 02 Jan 2019 00:55:34 CTX-Ms have become the most prevalent ESBLs worldwide with many variants described (Shakil & Khan, 2010) . CTX-M-15 is a particularly common enzyme that differs from CTX-M-3 by a single amino acid (D240G) (Cheng et al., 2010) . As a result of this D240G substitution, the interaction between the residues Gly 240 and Asn 270 was found to be absent in the CTX-M-15 enzyme. The absence of this interaction in CTX-M-15 increased the flexibility of the Cterminal of the b3 strand of the enzyme, this flexibility allows the accommodation of more varied substrates with respect to their size and three-dimensional structures. Hence, the CTX-M-15 enzyme is known to hydrolyse cefotaxime and ceftazidime, as well as cefepime, efficiently. The CTX-M-15 enzyme is increasingly being reported from India in association with TEM-1 (Muzaheed et al., 2009) . We had previously reported ESBL-producing bacteria from patients with community-acquired urinary tract infections from the same region; 42 % of the isolates were detected to produce ESBL among which 34.42 % were Escherichia coli (Akram et al., 2007) . Due to the lack of use of standard microbiological techniques, there is a paucity of ESBL data concerning neonatal infections, particularly in the population being studied (North Indian Infants of the Aligarh region). Moreover, E. coli is the most common cause of neonatal sepsis by Gram-negative bacteria (Kaufman & Fairchild, 2004) .
To the best of our knowledge, there has been no study regarding acquisition of ESBLs in neonates from this region of North India with respect to the sex of the neonates. An Indian study (from South India) found that increased antibiotic usage was significantly associated with the male sex among neonates (Narayan & Mathai, 2005) . Some authors have observed male neonates to be more prone to infections (Pessoa-Silva et al., 2001) . This prompted us to perform multiple logistic regression analysis with the aim of identifying independent factors that are significantly associated with ESBL-producing E. coli acquisition among male and female infants Accordingly, this study aimed to: (i) characterize the mode of transmission of bla CTX-M and bla TEM among ESBLproducing E. coli strains isolated from patients admitted to NICUs, and (ii) identify factors associated with acquisition of the said strains in male and female neonates.
METHODS
Collection of bacterial strains and patient details. The study was conducted at the NICU of Aligarh Hospital, Aligarh, India (from January 2006 to February 2007 . Patients enrolled in the analysis were those enrolled in the active surveillance system (NICU stay .48 h and weekly surveillance swabs taken at least once). Neonates admitted to the ward before January 2006 and/or discharged after February 2007 were excluded. Demographic and other relevant details were retrieved from medical records. A total of 32 factors were analysed with respect to the sex of the neonates. With the exception of 'length of stay in the NICU', length of exposure to the other time-dependent factors was evaluated until the first positive culture for ESBL-producing E. coli was obtained. Table 1 shows analysis of resistance markers based on clinical profile. Table 2 shows characteristics of the neonates positive for acquisition of ESBL-producing E. coli with respect to gender.
Microbiological methods. Strains of E. coli were isolated from the nose, pharynx and rectum of each neonate using surveillance swabs (analysed weekly) as well as clinical samples from the neonates. Standard methods for isolation and identification of bacteria were used (Cowan & Steel, 1970) . 16S rDNA sequencing was used to confirm bacterial identities (as strains of E. coli) using universal primers 27F and 1525R (Allen et al., 2007) , and sequences were compared with known E. coli 16S rDNA sequences in the GenBank database. Antimicrobial susceptibility testing of the isolates for the test antibiotics was performed by the standard disc diffusion method as recommended by the Clinical and Laboratory Standards Institute (CLSI, 2009) . MICs for the same antimicrobials were determined by the CLSI microbroth dilution method (CLSI, 2009) . The ESBL synergy test for the study isolates was performed as described by Jarlier et al. (1988) .
Molecular methods. Enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) was used for the analysis of genetic relatedness of the ESBL producers as described by Versalovic et al. (1991) . A search for bla CTX-M , bla TEM , armA, rmtA and rmtB genes and integrons in the genomic and plasmidic DNA of isolates that were positive for the ESBL synergy test was performed by PCR amplification, as described elsewhere (Galimand et al., 2003; Pagani et al., 2003; Doi et al., 2004; Lee et al., 2006; Park et al., 2006) . PCR amplified bla CTX-M genes were cloned using a Cloningplus kit (Qiagen) and sequencing was performed using an ABI 3130 genetic analyzer (Applied Biosystems). E. coli strains that were PCR positive for any of the tested genes were used as donors in transconjugation experiments (broth mating). Transformation was performed for the strains in which conjugation failed repeatedly.
Statistical analysis. Significance of the association of study variables with acquisition of ESBL-producing E. coli strains in male and female neonates was tested by Student's t test or Fisher's exact test as appropriate. All study factors that proved to be statistically significant on univariate analysis were entered by blockwise entry in a logistic regression model after exclusion of multicollinearity and interaction between variables. A two-tailed P value of ,0.05 was taken as significant. Statistical analysis was performed using SPSS (version 11.5; SPSS).
Nucleotide sequence accession numbers The GenBank accession numbers of the E. coli genes sequenced in this study are FJ997864, FJ997865, GQ145216, GQ145217, GQ145221, GQ145222, GQ174503, GQ174504 and GQ174505.
RESULTS AND DISCUSSION
During the study period, 253 neonates were admitted to the NICU. A total of 266 E. coli strains were isolated from the 238 neonates who met the criteria for inclusion in the active surveillance system. Only a single E. coli isolate was analysed per neonate. Characteristics of male and female neonates positive for acquisition (i.e. colonization or infection) of ESBL-producing E. coli were recorded (Table 2) . Among the 97 neonates positive for said acquisition, 78 (80.41 %) were males while 19 (19.59 %) were females ( Table 2 ). The mode of delivery for more than half of these neonates was Caesarean (n563; 64.9 %). Two male and one female neonates died.
Marker transfer experiments demonstrated plasmidmediated transfer of cefotaxime and ceftazidime resistance markers. ERIC-PCR divided the 83 ESBL-producers into 29 major profiles (Fig. 1) . Four bla CTX-M-15 positive strains, namely D8, D183, D295 and D296, were found to have identical profiles. These strains were temporally related and represented a clonal outbreak.
Susceptibility testing, ESBL detection, PCR and sequence analysis
A total of 97 (36.5 %) ESBL producers were identified among the 266 E. coli isolates. A single ESBL-producing E. coli was recovered per neonate. Fig. 2 shows the distribution of ESBLproducing E. coli obtained from neonates divided into 2 month periods from January 2006 to February 2007. There was no statistically significant increase in ESBL-producing E. coli strains over the time period studied. Antibioticsusceptibility tests were performed for all the isolates (data not shown). Four isolates were found to be imipenem resistant, while 37.97 % (n5101) isolates showed resistance against cefepime. Imipenem was found to be the drug of choice against the study isolates. This was consistent with one of our earlier studies (Akram et al., 2007) . The bla CTX-M-15 positive strains had a ceftazidime MIC of 32-64 mg l
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. The highest MIC against cefotaxime (512 mg l
) was observed for strain D295. The highest MIC against gentamicin (1024 mg l
) was observed for the rmtB positive strain D203. The presence of strains co-resistant to aminoglycosides, quinolones and third-generation cephalosporins was also observed in our setting. Such strains if combined with the production of carbapenemase might result in therapeutic dead ends (Walsh, 2008) , which is a matter of concern.
Five bla CTX-M , two rmtB and two bla TEM genes, and 13 integrons were amplified. The rationale behind the screening of aminoglycoside-resistance genes was that in recent years there has been an increase in reports describing concomitant b-lactam and aminoglycoside resistance (involving armA and rmtB genes) in hospitals from the Indian subcontinent (Ma et al., 2009) . Furthermore, in the NICU of Aligarh Hospital, India, we rotate gentamicin and amikacin, each for 6 months to minimize the emergence of resistance and these drugs (aminoglycosides) are often a default choice for empirical treatment of neonatal infections in our NICU. Simultaneous resistance to advanced generation cephalosporins (due to ESBLs) and aminoglycosides is posing a serious threat in our North Indian hospitals. However, it was encouraging that none of the strains were simultaneously positive for bla CTX-M and any of the 16S rRNA methyltransferase genes. Also, none of the strains harboured armA or rmtA. Only 5 of our 97 ESBLproducing strains were PCR positive for bla . This is in harmony with a study in which the authors detected only 3 strains out of 365 clinical isolates that were PCRpositive for bla CTX-M-15 (Touati et al., 2006) . However, this observation was contrary to many findings, which have reported a high prevalence of bla CTX-M-15 among clinical isolates (Muzaheed et al., 2008) . ESBL production in the remaining ESBL-positive strains might be due to ESBL types other than CTX-Ms such as SHV/OXA/TEM/GES/ ESBL acquisition in male and female infants BES/PER/TLA/IBC etc. as each of these have many variants. Class 1 integrons are the most commonly found integron type in Gram-negative bacteria (Khemtong & Chuanchuen, 2008) . Accordingly, we detected 13 class 1 integrons all of which were invariably PCR positive for int1 and sul1. The plasmid extraction, transformation, cloning and sequencing studies were used to rule out the emergence of any novel variant of CTX-M family with an altered substrate profile. None of the mutations obtained in our CTX-M-15 sequences was located within the omega loop (Bonnet et al., 2001) or other positions that are known to affect catalytic properties or substrate profile of these enzymes (Schneider et al., 2009) . Hence the MIC values for cefotaxime and ceftazidime antibiotics in these isolates were typical of CTX-M-15 producers. The bla CTX-M-15 positive isolates displayed cefotaxime MICs up to eightfold higher than ceftazidime MICs.
Outcome of risk factor analysis
The term 'acquisition' is a generalized term that can refer to both 'infection' and 'colonization'. Several authors have investigated the association of different study variables with 'ESBL and non-ESBL-producing E. coli or Klebsiella pneumoniae acquisition status' of paediatric patients (Kim et al., 2007; Crivaro et al., 2007) . The significance of Fig. 1 . ERIC-PCR profiles of ESBL-producing E. coli isolated from neonates. ERIC-PCR of the 83 ESBL producers gave 29 major profiles. Strains D8, D183, D295 and D296 were found to be clonally related and displayed ERIC-PCR profile X1, while D282 displayed an unrelated profile K. The most common profile, B1, was shared by 13 strains. M, Marker.
factors for neonatal infection and mortality with respect to gender was also investigated some time ago (Berman et al., 1987) . This is believed to be the first study from this part of the world (North India), which identifies significant factors associated with acquisition of ESBL-producing E. coli strains in male and female neonates. Univariate analysis of various study variables was performed for the 97 neonates who were positive for 'ESBL-producing E. coli acquisition'. In the univariate analysis, many study variables including mode of delivery, birth weights, length of stay in the NICU etc. (all P,0.05) were found to be significant (Table 2) . However, there was no significant gender difference in neonatal mortality (P50.49) as observed by Berman et al. (1987) . The multiple logistic regression model confirmed length of stay in the NICU to be the single independent factor associated with acquisition of ESBL-producing E. coli strains in male and female neonates (P50.001). Hence, male neonates who are colonized or infected by ESBLproducing E. coli might have a longer stay in a NICU compared to their female counterparts. Male neonates have been considered more prone to infections by some authors (Pessoa-Silva et al., 2001) . Accordingly, the mean length of stay in the NICU was considerably higher for the male neonates (Table 2 ). This prolonged stay for male neonates might be the consequence of one of the following events. First, male infants become sicker once they are colonized/ infected by ESBL-producing strains. Second, male infants get colonized/infected earlier in their stay. Third, male neonates are more likely to get an invasive infection when they are exposed to an ESBL-producing strain whereas their female counterparts merely get colonized. Any of these might result in an overall longer NICU stay. A closer examination of the medical records revealed that the prolonged stay was due to male neonates becoming colonized/infected earlier in their stay than their female counterparts. It is also important to mention here that the striking difference in the number of male versus female infants found to be colonized/infected with an ESBL-producing strain might also be due to an overall gender bias within the NICU itself. The percentage of male and female infants in the study period was 66 and 34 %, respectively. But, this gender bias was duly taken into account in statistical analysis. The length of stay mentioned in Table 2 , refers to mean length of NICU stay per neonate (either male or female). Hence, gender bias does not affect the main conclusion of the study that the said male neonates have a longer NICU stay. Several authors have found birth weight as a significant factor for neonatal infection (Simchen et al., 2000) , which was found to be insignificant in the final multiple regression analysis in our setting.
Conclusions
Our data demonstrate that male neonates who are colonized or infected by ESBL-producing E. coli have a longer stay in the NICU compared to their female counterparts. This prolonged stay is in turn a result of male neonates becoming colonized/infected earlier than their female counterparts. Sequencing results ruled out the emergence of any novel CTX-M-variants. Plasmidmediated-conjugal transfer was found to be the mechanism of transfer of the bla CTX-M-15 resistance marker in the described setting. 
